
NanoScout is a pioneering company that offers a cloud-based AI platform for high-resolution nanoscale detection and diagnostics. Their patented technology integrates Scanning Electron Microscopy (SEM) with advanced AI algorithms to identify pathogens, impurities, and infections across multiple sectors including healthcare, environmental monitoring, industrial processes, and bioresearch. Founded in 2020 and based in Tel Aviv, Israel, NanoScout serves hospitals, universities, and companies by providing rapid, accurate, and cost-effective testing solutions. Their BioQA product enhances microbial analysis and antimicrobial resistance monitoring, supporting early disease detection and drug discovery. The company is staffed by a multidisciplinary team of medical professionals, biochemists, biologists, computer scientists, and physicists, positioning NanoScout as a leader in next-generation pan-microbial detection and screening technology.

NanoScout is a pioneering company that offers a cloud-based AI platform for high-resolution nanoscale detection and diagnostics. Their patented technology integrates Scanning Electron Microscopy (SEM) with advanced AI algorithms to identify pathogens, impurities, and infections across multiple sectors including healthcare, environmental monitoring, industrial processes, and bioresearch. Founded in 2020 and based in Tel Aviv, Israel, NanoScout serves hospitals, universities, and companies by providing rapid, accurate, and cost-effective testing solutions. Their BioQA product enhances microbial analysis and antimicrobial resistance monitoring, supporting early disease detection and drug discovery. The company is staffed by a multidisciplinary team of medical professionals, biochemists, biologists, computer scientists, and physicists, positioning NanoScout as a leader in next-generation pan-microbial detection and screening technology.